Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥2,878 JPY
Change Today +69.00 / 2.46%
Volume 656.1K
4541 On Other Exchanges
Symbol
Exchange
OTC US
Tokyo
As of 2:00 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

nichi-iko pharmaceutical co (4541) Snapshot

Open
¥2,840
Previous Close
¥2,809
Day High
¥2,919
Day Low
¥2,818
52 Week High
04/14/15 - ¥2,961
52 Week Low
08/7/14 - ¥1,434
Market Cap
174.6B
Average Volume 10 Days
507.0K
EPS TTM
¥110.26
Shares Outstanding
60.7M
EX-Date
09/28/15
P/E TM
26.1x
Dividend
¥26.60
Dividend Yield
0.92%
Current Stock Chart for NICHI-IKO PHARMACEUTICAL CO (4541)

Related News

No related news articles were found.

nichi-iko pharmaceutical co (4541) Related Businessweek News

No Related Businessweek News Found

nichi-iko pharmaceutical co (4541) Details

Nichi-Iko Pharmaceutical Co., Ltd. is engaged in the manufacture, sale, distribution, export, import, and related activities for various pharmaceuticals. The company primarily focuses on the production of generic drugs. It also offers treatments for circulatory, digestive, respiratory, and central and peripheral nervous system disorders. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was founded in 1965 and is headquartered in Toyama, Japan.

Founded in 1965

nichi-iko pharmaceutical co (4541) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nichi-iko pharmaceutical co (4541) Key Developments

Nichi-Iko Pharmaceutical Co., Ltd. to Report Fiscal Year 2015 Results on May 12, 2015

Nichi-Iko Pharmaceutical Co., Ltd. announced that they will report fiscal year 2015 results at 1:00 PM, Tokyo Standard Time on May 12, 2015

Nichi-Iko Pharmaceutical Co., Ltd., 2015 Earnings Call, May 13, 2015

Nichi-Iko Pharmaceutical Co., Ltd., 2015 Earnings Call, May 13, 2015

Nichi-Iko Pharmaceutical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2014; Provides Dividend Guidance for the Year Ending March 31, 2015; Provides Earnings Guidance for the Year Ending March 31, 2015

Nichi-Iko Pharmaceutical Co., Ltd. reported consolidated earnings results for the nine months ended December 31, 2014. For the quarter, the company reported net sales of JPY 95,860 million against JPY 78,378 million a year ago. Operating income was JPY 7,880 million against JPY 6,447 million a year ago. Ordinary income was JPY 7,787 million against JPY 6,305 million a year ago. Net income was JPY 5,188 million against JPY 4,088 million a year ago. Diluted net income per share was JPY 86.69 against JPY 100.05 a year ago. Net income before provision for income taxes were of JPY 7,896 million compared to JPY 6,275 million a year ago. The company provided dividend guidance for the year ending March 31, 2015. For the period, the company expects to pay year end dividend of JPY 14.30 compared to dividend of JPY 12.30 a year ago. For the year ending March 31, 2015, the company expects net sales of JPY 123,000 million, operating income of JPY 9,300 million, ordinary income of JPY 9,000, and net income of JPY 5,900 million or net income per share of JPY 98.67.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4541:JP ¥2,878.00 JPY +69.00

4541 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4541.
View Industry Companies
 

Industry Analysis

4541

Industry Average

Valuation 4541 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NICHI-IKO PHARMACEUTICAL CO, please visit www.nichiiko.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.